Cargando…
Serum Fibroblast Growth Factor 21 and New-Onset Metabolic Syndrome: KoGES-ARIRANG Study
PURPOSE: Fibroblast growth factor 21 (FGF21) is a crucial metabolic regulator, with multiple favorable effects on glucose homeostasis and lipid metabolism. Since serum FGF21 level has been implicated as a potential marker for the early identification of metabolic syndrome (MetS), we investigated the...
Autores principales: | Choi, Jung Ran, Kim, Jang-Young, Park, Il Hwan, Huh, Ji Hye, Kim, Ki Woo, Cha, Seung-Kuy, Park, Kyu-Sang, Sohn, Joon Hyung, Park, Jong Taek, Koh, Sang Baek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823832/ https://www.ncbi.nlm.nih.gov/pubmed/29436198 http://dx.doi.org/10.3349/ymj.2018.59.2.287 |
Ejemplares similares
-
A Prospective Study of Fatty Liver Index and Incident Hypertension: The KoGES-ARIRANG Study
por: Huh, Ji Hye, et al.
Publicado: (2015) -
Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study
por: Yadav, Dhananjay, et al.
Publicado: (2016) -
Serum leptin level and incidence of CKD: a longitudinal study of adult enrolled in the Korean genome and epidemiology study(KoGES)
por: Park, Yon Chul, et al.
Publicado: (2022) -
Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium
por: Kim, Yeonjung, et al.
Publicado: (2017) -
Cohort Profile: The Korean Genome and Epidemiology Study (KoGES) Consortium
por: Kim, Yeonjung, et al.
Publicado: (2017)